Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S2EP1 Unveiling the Promise: The Controversial Rise of Fenbendazole in Cancer Care"
Fenben® Voices
5 minutes
3 weeks ago
S2EP1 Unveiling the Promise: The Controversial Rise of Fenbendazole in Cancer Care"
Got Questions? Send us a message! Join us on this episode of "Fenben Voices" as we delve into the controversial topic of fenbendazole, a drug traditionally used for treating parasites in animals, now gaining attention as a potential cancer treatment. This episode explores the multifaceted debate surrounding its efficacy and safety, providing a balanced perspective on whether this treatment is a medical breakthrough or merely misplaced enthusiasm. Tune in as we discuss: Dewormer's Dual Role: A...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
